This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
CommunityPharmacies and Anabolic-Androgenic Steroid Consumers "With the growing availability of AAS [Anabolic-Androgenic Steroids] through online platforms [ 71 , 72 ] the traditional reliance on social networks and healthcare providers for access to injecting equipment and safer use information has diminished [ 73 – 76 ].
British consumers have increasingly turned to communitypharmacies during the coronavirus pandemic, according to a new study. Research conducted by Ipsos Mori and commissioned by Johnson & Johnson Consumer Health EMEA surveyed between 6,000 people between 16 and 75. This rose to 68% in the 45-54 age bracket.
The Lifeguard Pharmacy study tests whether a communitypharmacy response service would offer a discreet and accessible help-seeking avenue for people experiencing suicidal ideation and/or domestic abuse. Monthly visits to the pharmacies by the research team monitored intervention fidelity. How did we do it?
The use of opioid agonist treatment increased in non-communitypharmacy settings from early 2020. Increases were seen for buprenorphine. However, the number of client-months on methadone over the study period remained relatively stable. This increase was particularly evident in drug and alcohol outpatient clinics and prisons.
New research from Ipsos MORI has found that UK consumers have turned to community pharmacists during COVID-19 for healthcare advice and more. In addition to an increase in online engagement, 29% of UK consumers visited a pharmacy to buy healthcare products during the lockdown period.
Source link.
A new study by National Drug and Alcohol Research Centre (NDARC) researchers, led by PhD candidate Thomas Santo Jr, describes childhood trauma exposure among a sample of people prescribed opioids for CNCP. This type of e xposure is associated with neurobiological and psychosocial harm that may continue through adulthood.
More research is needed on optimal methadone dosing in patients with high opioid tolerance due to use of fentanyl, as well as on induction protocols for these patients. Although more research would be of value, the initial evidence suggests that providing methadone outside of OTPs is feasible, acceptable, and leads to good outcomes.
Together with DrugBank’s complementary products, this integration is expected to improve consumer safety, provide users with a stronger understanding of trends across categories and the research landscape, and enhance analytic capabilities.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content